US Judge Sides With FDA's ... Lilly's Weight Loss Drug From Shortage List By Patrick Wingrove (Reuters) -A U.S. federal judge has sided with a U.S. regulator's decision last year to ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

A federal judge has sided with the U.S. Food and Drug Administration over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine ... will no longer have ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

It is no longer Europe's most valuable ... deal to be listed as the preferred weight-loss drug for coverage on CVS's (CVS) formulary. This caused Lilly's stock to tank last week, but ...